In this episode, we’ll talk with Keith Grossman, who brought his long, successful track record as a medtech CEO to what he sees as a truly disruptive neurostimulation company. We’ll talk with Grossman about his decision to join medtech even though unlike some of his counterparts he enjoyed organic chemistry (aka, the Medtech career creator) in college. Over his career, Grossman helped create new medical device marks by leading companies such as Thoratec and Conceptus toward sizable acquisitions. At Nevro, Grossman says he’s overseeing the company’s transformation into a pain company, one that’s managed to grab 20% of a competitive market very quickly. Thanks to Pulse Technologies for sponsoring this episode.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to this podcast on any major podcast application.

Ver todos los episodios